For instance, functional studies have shown that down-regulation of ARL6IP5 in hepatocellular carcinoma (HCC) and non-small cell lung cancer can promote tumor invasion and predict a poor prognosis [23, 24]. Here, ARL6IP5 is linked to hepatocellular carcinoma.